GSK3B
Glycogen synthase kinase-3 beta
Also known as: GSK3B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49841
- Gene
- GSK3B
- Ensembl
- ENSG00000082701
- Chromosome
- 3
- Canonical length
- 420 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a serine-threonine kinase belonging to the glycogen synthase kinase subfamily. It is a negative regulator of glucose homeostasis and is involved in energy metabolism, inflammation, ER-stress, mitochondrial dysfunction, and apoptotic pathways. Defects in this gene have been associated with Parkinson disease and Alzheimer disease. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
420 residues, UniProt reviewed canonical sequence.
>P49841|GSK3B
1 MSGRPRTTSF AESCKPVQQP SAFGSMKVSR DKDGSKVTTV VATPGQGPDR PQEVSYTDTK
61 VIGNGSFGVV YQAKLCDSGE LVAIKKVLQD KRFKNRELQI MRKLDHCNIV RLRYFFYSSG
121 EKKDEVYLNL VLDYVPETVY RVARHYSRAK QTLPVIYVKL YMYQLFRSLA YIHSFGICHR
181 DIKPQNLLLD PDTAVLKLCD FGSAKQLVRG EPNVSYICSR YYRAPELIFG ATDYTSSIDV
241 WSAGCVLAEL LLGQPIFPGD SGVDQLVEII KVLGTPTREQ IREMNPNYTE FKFPQIKAHP
301 WTKVFRPRTP PEAIALCSRL LEYTPTARLT PLEACAHSFF DELRDPNVKL PNGRDTPALF
361 NFTTQELSSN PPLATILIPP HARIQAAAST PTNATAASDA NTGDRGQTNN AASASASNSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSK3B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- retina: 22 nTPM
- cerebral cortex: 20 nTPM
- thymus: 19 nTPM
- heart muscle: 17 nTPM
- testis: 17 nTPM
- tongue: 17 nTPM
Single-cell type
- neutrophils: 761 nCPM
- neutrophil progenitors: 424 nCPM
- corticotrophs: 332 nCPM
- microglia: 332 nCPM
- ocular epithelial cells: 323 nCPM
- oligodendrocyte progenitor cells: 313 nCPM
Immune cell
- neutrophil: 6.8 nTPM
- eosinophil: 6.3 nTPM
- non-classical monocyte: 2.2 nTPM
- classical monocyte: 1.8 nTPM
- memory CD8 T-cell: 1.7 nTPM
- intermediate monocyte: 1.6 nTPM
Brain region
- pons: 84 nTPM
- cerebellum: 83 nTPM
- cerebral cortex: 82 nTPM
- midbrain: 82 nTPM
- medulla oblongata: 81 nTPM
- hypothalamus: 78 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GSK3B.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 76 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 2.8
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- beta-arrestin-dependent dopamine receptor signaling pathway
- canonical Wnt signaling pathway
- cell differentiation
- cellular response to amyloid-beta
- cellular response to interleukin-3
- cellular response to retinoic acid
- circadian rhythm
- epithelial to mesenchymal transition
- ER overload response
- establishment of cell polarity
- excitatory postsynaptic potential
- extrinsic apoptotic signaling pathway
- extrinsic apoptotic signaling pathway in absence of ligand
- glycogen metabolic process
- heart valve development
- hippocampus development
- insulin receptor signaling pathway
- intracellular signal transduction
- maintenance of cell polarity
- mitochondrion organization
- negative regulation of apoptotic process
- negative regulation of calcineurin-NFAT signaling cascade
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell migration
- negative regulation of dopaminergic neuron differentiation
- negative regulation of epithelial to mesenchymal transition
- negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- negative regulation of gene expression
- negative regulation of glycogen (starch) synthase activity
- negative regulation of glycogen biosynthetic process
- negative regulation of mesenchymal stem cell differentiation
- negative regulation of osteoblast differentiation
- negative regulation of protein localization to nucleus
- negative regulation of protein-containing complex assembly
- negative regulation of TOR signaling
- negative regulation of TORC2 signaling
- negative regulation of type B pancreatic cell development
- neuron projection development
- peptidyl-serine phosphorylation
- positive regulation of autophagy
- positive regulation of cell differentiation
- positive regulation of cell-matrix adhesion
- positive regulation of cilium assembly
- positive regulation of gene expression
- positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- positive regulation of neuron apoptotic process
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of protein binding
- positive regulation of protein catabolic process
- positive regulation of protein export from nucleus
- positive regulation of protein localization to centrosome
- positive regulation of protein localization to cilium
- positive regulation of protein ubiquitination
- positive regulation of protein-containing complex assembly
- positive regulation of type I interferon production
- presynaptic modulation of chemical synaptic transmission
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein autophosphorylation
- protein phosphorylation
- regulation of axon extension
- regulation of axonogenesis
- regulation of cellular response to heat
- regulation of circadian rhythm
- regulation of dendrite morphogenesis
- regulation of long-term synaptic potentiation
- regulation of microtubule cytoskeleton organization
- regulation of microtubule-based process
- regulation of neuron projection development
- regulation of protein export from nucleus
- response to endoplasmic reticulum stress
- superior temporal gyrus development
- viral protein processing
- Wnt signaling pathway
- neuron projection organization
- regulation of microtubule anchoring at centrosome
Molecular functions
- ATP binding
- beta-catenin binding
- dynactin binding
- kinase activity
- NF-kappaB binding
- p53 binding
- protease binding
- protein kinase A catalytic subunit binding
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- RNA polymerase II-specific DNA-binding transcription factor binding
- scaffold protein binding
- tau protein binding
- tau-protein kinase activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
- ADP-ribosylation
- Alzheimer disease
- ATP-binding
- Biological rhythms
- Carbohydrate metabolism
- Cell membrane
- Cytoplasm
- Developmental protein
- Diabetes mellitus
- Differentiation
- Glycogen metabolism
- Kinase
- Lipoprotein
- Membrane
- Neurogenesis
- Nucleotide-binding
- Nucleus
- Palmitate
- Phosphoprotein
- Serine/threonine-protein kinase
- Signal transduction inhibitor
- Transferase
- Wnt signaling pathway
InteractionsUniProt · HPA
Protein binding partners of GSK3B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSK3B as an antibody target. Whether an autoantibody or antibody against GSK3B could matter depends on whether native GSK3B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSK3B is annotated at the cell surface, where native GSK3B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GSK3B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...